Category Archives: Publications

New Book – Principles of Anticancer Drug Development

Recently, Humana Press/Springer published a new book, Principles of Anticancer Drug Development. Neil Clendeninn M.D., Ph.D., a Senior Clinical Research Physician for Cato Research, served as an editor for the book, which has been described as a practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs. Continue reading

Posted in Publications | Tagged , , , , , , , , , , , | Comments Off on New Book – Principles of Anticancer Drug Development

Biotech Financing: Those That Adapt to Change Will Survive

In the October issue of Biotechnology Focus, Cato Research’s very own Chief Financial Officer and Principal of Cato BioVentures, Daniel Pharand, discusses the recent shift and latest trends in financing within the biotechnology industry.  “There have been a number of … Continue reading

Posted in Publications, Venture Capital | Tagged , , , , | 1 Comment

Important Steps Forward for Early Detection and Diagnose of Alzheimer’s Disease

Image via Wikipedia In a recent report by Geert De Meyer of Ghent University in Belgium and colleagues, titled “Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People” (Arch Neurol. 2010;67(8):949-956) it was demonstrated that measuring certain proteins in … Continue reading

Posted in Clinical Trials, Conferences and Meetings, Industry News, Publications | Tagged , , , , , | Comments Off on Important Steps Forward for Early Detection and Diagnose of Alzheimer’s Disease

Advice from the FDA, Part 2: Making Your eCTD Submission Reviewer-Friendly

Cato’s Director of Regulatory Operations, Evan Richardson, authored a guest blog post featured on today. is the website for Pharmaceutical Processing magazine, offering a wealth of  information on products, technologies and applications for pharmaceutical and biopharmaceutical professionals. Evan’s … Continue reading

Posted in eCTD, Guest Posts, Publications, Social Media | Tagged , , , | 1 Comment

Approval of Therapeutic Cancer Vaccines

Last month, Dendreon was granted approval for Provenge®, the first cell based cancer vaccine for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  Provenge is the first cancer treatment that utilizes the strength of the … Continue reading

Posted in FDA, Industry News, Publications | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment